08 — Evidence Pathway
Diagnostic innovation must earn analytical validation, clinical validation, quality controls and regulatory review before clinical use.
Evidence Planning · Future ValidationProduct development and clinical claims are separate stages — no claim should be made before evidence.
Validation is the foundation of responsible diagnostics. Building a platform and proving a clinical claim are different things — we hold them apart deliberately.
So we say validation planned, validation pathway, future evidence generation. We under-claim by design and earn trust rather than overstate our stage.
Every step below is planned or future. None is complete. None is presented as achieved.
Precision, repeatability, interference, stability and linearity — planned, not yet performed.
Studies with reference-method comparison across diverse populations — intended, not conducted.
A regulatory review pathway, planned before any diagnostic claim.
A future goal that depends on completing the steps above.
We would rather understate our stage than overstate it and lose trust.
The planned work behind the pathway — described as intent and direction, never as a result in hand.
Planned: precision, interference, stability, linearity and sample-type evaluation.
Future studies, reference-method comparison, diverse populations.
Invalid-result handling and quality checks, built in from the start.
Approved labeling and regulatory review before any diagnostic claim.
Validation planned, validation pathway, future evidence generation.
We do not overclaim. Trust is earned through discipline, not hype.
Tell us who you are and how you'd like to collaborate.
Shared only with the BIQADX team · no spam.
